Sign up to save your podcasts
Or
Share Optimizing Frontline ADCs: Sequencing, Targets, and Resistance
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Optimizing Frontline ADCs: Sequencing, Targets, and Resistance
Dr. Pedro Barata and Dr. Giuseppe Curigliano discuss the rapid paradigm shift of antibody-drug conjugates into frontline advanced and curative-intent perioperative settings and the clinical challenges of optimal sequencing, target selection, and cross-resistance.
LINK TO FULL TRANSCRIPT
View all episodes
By American Society of Clinical Oncology (ASCO)
4.5
3131 ratings
Dr. Pedro Barata and Dr. Giuseppe Curigliano discuss the rapid paradigm shift of antibody-drug conjugates into frontline advanced and curative-intent perioperative settings and the clinical challenges of optimal sequencing, target selection, and cross-resistance.
LINK TO FULL TRANSCRIPT
More shows like ASCO Education
View all
NEJM This Week
319 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
JCO Oncology Practice Podcast
17 Listeners
ASCO Daily News
57 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
ASCO Guidelines
47 Listeners
The Readout Loud
337 Listeners
OncLive® On Air
24 Listeners
Money Meets Medicine
228 Listeners
Oncology Today with Dr Neil Love
59 Listeners
The Foreign Affairs Interview
469 Listeners
Not Otherwise Specified
59 Listeners
Two Onc Docs
195 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
46 Listeners
The Best People with Nicolle Wallace
4,242 Listeners